)
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 12/11/2015 9:40 AM, e.olof...@lumc.nl wrote:
Usually tolerance criteria for ODE solvers apply
/simplifications/improvements, including
changing the estimation method (try FO if nothing helps, and then used
FO final estimates to start something more advanced)
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail
Hi Dennis,
Bootstrap would be an obvious choice (for the entire range of Cp
values): fit 1000 models to 1000 sets, and for each X value compute CI of Y.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail
and W in the Nonmem output file (that you read to
the R data frame "data"), you can re-define
if(BQL == 1) data$PRED = data$LLOQ - qnorm(data$PRED)*data$W# R code
(I have not tested it; use on your own risk :) )
Leonid
------
Leonid Gibia
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
values
you can use FNLETA=0; then Nonmem will use estimation step etas to
compute individual predictions.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 9/27
all
known genotypes.
Leonid
------
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 9/23/2015 4:44 AM, ykl7 . wrote:
Dear NMusers,
I would like to investigate the effect of several genotypes
)
assumptions about random effect structure. I would rather use explicit
assumptions.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 9/11/2015 1:38 PM, Penny Zhu
model and the structure of the IIV model (ETAs on CL, or V, or
both equal, etc.). You may get some rough idea about the magnitude of
the IIV but you may need strong assumptions about the residual and IIV
model.
Leonid
--
Leonid Gibiansky, Ph.D.
President
value
K = THETA(2)*EXP(ETA(2)) ; rate of decay
TY = C0*EXP(-K*TIME) ; individual prediction
Y = TY*(1+EPS(1)); proportional error model
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky
does it mean "disappear"; may be area inside the loop is
small). The time shift that provides smallest hysteresis area is the
delay time.
Leonid
------
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail:
Dear All,
We plan to present a TMDD workshop at ACoP (October 8th, 2015, see
below) but the current enrollment is near the low boundary of workshop
acceptance limit. If you plan to attend, could you please register at
ACoP web site or let me know (by replying to me, not to nmusers group)
if
one option is to use BASE and KOUT as primary parameters and compute
KIN=BASE*KOUT
Then one can either fix BASE=(observed base) or use
BASE=(observed base)*EXP(ETA())
to account for the random noise of observations.
Leonid
--
Leonid Gibiansky, Ph.D
) for MYETA matrix
that is forbidden by the band matrix for ETA(1:4).
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 7/3/2015 9:58 AM, Gavin Jarvis wrote:
Dear
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 6/23/2015 4:48 AM, Faelens, Ruben (Belgium) wrote:
Dear NONMEM users,
We all know how difficult it is to simulate full drug
(1) = 1, this will set F1 to 1/2
$ERROR
IPRED=Y ; this is PD measure that need to be above 100
IF(IPRED.LT.100) COM(1)=1 ; if PD drops below 100 at any time, halve
future doses
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
Dear All
After some break, QuantPharm LLC (Leonid Gibiansky and Ekaterina
Gibiansky) will again present the workshop on Modeling of Biologics with
Target-Mediated Disposition as a satellite workshop of ACoP6 conference,
October 8, 2015.
The TMDD workshop provides an overview of the PK
but you should be able to see it by increasing
or decreasing the number of transit compartments.
Regards,
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 6/12
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 4/20/2015 12:12 PM, Diane-Charlotte Imbs wrote:
Dear nonmem users,
We used the option “-2 RATE” of NONMEM (actual rate
machines?
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 3/30/2015 7:32 PM, Bauer, Robert wrote:
Dear nmusers:
Some of you may have been starting
representations are related (approximately) as
SE(THETA2)=SE(THETA(1))/THETA(1)
(propagation of error rule). Given SE(THETA(1)) and THETA(1) you can
estimate SE(THETA(2)) and simulate accordingly.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm
), but for intermediate
steps or models with multi-day runs, SEs are very helpful and
sufficiently reliable.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
the estimate of the PK
parameter for missing level is somewhere between the estimates for
NO and YES levels, closer to the value for the level with higher
prevalence in your dataset.
Regards,
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
Mark,
I reproduced the setup and your file is running fine on my side (after
we switched off all the firewalls)
Thanks for your help!
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
Dear All,
We cannot force Nonmem parallel to run on two Windows 7 computers. If
anybody was able to do it (on Windows machines, with Windows 7 systems)
could you share the pnm file?
Thanks!
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
they have high CWRES but due to some
timing or dosing errors that could be obvious from looking on the plots)
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 9
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 8/27/2014 12:21 PM, Jiang, Yu wrote:
Dear Lenonid,
Thank you for your suggestion! That is very helpful. But I am
one population (same
population KA for all subjects) but allow high inter-occasion variability.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 8/26/2014
software may or may not work as is.
Thanks!
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 2/17/2014 3:22 AM, Seng Kok Yong wrote:
Dear fellow NMusers,
I'm trying to develop an integrated parent-metabolite PK model
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 1/6/2014 6:53 AM, 赵赵 wrote:
Dear Dr Leonid,
Thanks so much! Your answer gave me a very clear direction of what to do
or RMSE that are more or less useless in identifying
the direction of the bias (if you have any differences with the
literature models).
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
, it could be better to use more
mechanistically relevant model and put the variability where it would be
expected from the mechanistic point of view.
Regards,
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky
()*EXP(ETA())/FF1
but not
F1=EXP(ETA(1))
CL=THETA()*EXP(ETA())/F1
V=THETA()*EXP(ETA())/F1
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 11/22/2013 12:14
Is this a simulation run? May be residual error? I never seen integration
problem to result in incorrect profiles. Also check the data file, may be extra
dose was given?
Leonid
On Nov 2, 2013, at 8:01 PM, non...@optonline.net wrote:
Hello NONMEM Users,
NONMEM outputs for few
of point of views on this subject :)
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 10/22/2013 4:17 AM, Xinting Wang wrote:
Dear Nick,
Thank you very much
Justus
This looks OK except you need to assign F1=1 for IV, so it should be
F1=1
IF(ROUT.EQ.SC) F1=THETA(4)
where ROUT is a covariate that is equal to SC for SC administration
subjects or doses.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
agreement with
the bootstrap CI, but it may depend on the problem.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 10/8/2013 3:57 AM, Xinting Wang wrote:
Dear
It looks like a bug (or feature). Nonmem can handle
$OMEGA BLOCK(2)
1
1 1
but fails on
$OMEGA BLOCK(2)
1
0 0
although conceptually these are identical problems
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail
it be divided by the parameter value?
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 10/8/2013 10:50 AM, pavan kumar wrote:
Hi,
I have been working
(different)
while for the second model they are equal to
SLOPE = THETA(3)+ETA(2)
SLOPE = THETA(3)+ETA(2)
and equal to each other
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel
where root is the
name of the control stream, you will find there the OBJ value and SD
(averaged over the iterations). Those values can be used for model
comparison.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e
modeling are provided to the participants.
More details can be found here:
http://www.quantpharm.com/Workshop.html
The link below contains registration details:
http://www.iconplc.com/news-events/events/workshops/a-1-day-workshop-on-model/index.xml
Thanks!
Leonid
--
Leonid Gibiansky, Ph.D
. If you are interested to
combine TMDD workshop with Nonmem worskops, you can review those and
register here:
http://www.iconplc.com/news-events/events/workshops/
Thanks!
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 8/10/2013 10:23 PM, Xinting Wang wrote:
Dear all,
Does anyone witnessed such a phenomenon in NONMEM as when you reduced an
ETA
It is not a good idea to use enclosed IF loops. Use
CODE1=0
IF(GENE.EQ.1) CODE1=1
CODE4=0
IF(GENE.EQ.4) CODE4=1
CL=(CODE1*THETA(1)+...+CODE4*THETA(4))*EXP(ETA(1))
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e
be at least 6 (if at all possible: could be possible with ADVAN13)
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 7/24/2013 3:29 PM, markus joerger wrote:
dear
)
Param1 = EXP(MU_1+ETA(1))
Param = Param1*EXP(ETA(2)*G2)
I would also try correlated ETA(1) and ETA(2), and I wonder whether they
will be estimated as collinear.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail
should it be IF(MIXEST.EQ.2) Z=0 for the fitting run?
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 5/7/2013 11:31 AM, Paul Hutson wrote:
Dear Users:
I note
Well, it was the wrong guess, MIXNUM should work
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
should it be IF(MIXEST.EQ.2) Z=0 for the fitting run?
On 5/7/2013
places available as we were able to find a larger room.
Also a sufficient number of industry participants registered, so we are
lifting restrictions on the number of student (discount registration)
places.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D
in your
scale but preferably large relative to the integration steps) and
P=DOSE/duration.
Not straightforward but doable
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel
(where T1 is known in advance)?
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 4/3/2013 4:35 PM, Yaming Hang wrote:
Dear NONMEM Users,
I have some questions
Not to diminish the significance of ACoP, but there are other
conferences (PAGE, WCoP, PKUK) that are also 100% dedicated to
furthering the emerging scientific discipline of pharmacometrics
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
can be found in any of the following links:
http://www.meetingmakers.co.uk/userfiles/file/PAGE%202013%20Satellite%20Workshop%20PDF.pdf
http://www.quantpharm.com/Workshop.html
http://www.meetingmakers.co.uk/page-satellite-workshop.asp
Thanks
Leonid
--
Leonid
). I would try to run the initial model with
NOTHETABOUNDTEST NOOMEGABOUNDTEST NOSIGMABOUNDTEST
options.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
Nele,
You can use T in $DES block if you use ADVAN6, 8, 9, or 13 and write you
system in differential equations
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767
but if there is any trend, it should
be clearly visible on the plot.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 1/9/2013 5:19 AM, Gavin Jarvis wrote:
Dear
to reproduce
it on his side, but he helped to pin-point the blame on the MPI since
FPI runs fine on the same runs. Has anybody else seen this problem, and
if yes, were you able to fix it?
Thanks!
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 12/15/2012 3:24 AM, markus joerger wrote:
dear NMUSERS,
I am presently working on a capecitabine model (n=12, increasing levels
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 11/27/2012 1:59 PM, pascal.gir...@merckgroup.com wrote:
Hi Leonid,
Thanks for the additional suggestion to use ADVAN13. I was able
Hi Pascal,
You may want to switch to ADVAN13. It is much more stable for stiff
problems, and may allow to increase TOL.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel
Actually, it is useful, we did is many times (but then got a better UPS :) )
Leonid
On 8/14/2012 12:37 PM, non...@optonline.net wrote:
Hello Everyone,
It seems like the $MSFI is not useful if the NONMEM job crash due to,
for example, power outage. Are there any other way to resturt the
, see
http://www.page-meeting.org/default.asp?abstract=1595
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 7/6/2012 3:30 PM, Wang, Xiaofeng wrote:
Dear
to
the reference dose that you would like to use).
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 7/5/2012 12:16 PM, siwei Dai wrote:
Hi, Everyone:
I am having
this error model inflates variance too strongly (at low TY
values). Then something like EMAX error model in logs can help:
W = THETA() - THETA()*TY/(THETA()+TY)
Y = LOG(TY) + W*EPS(1) ;
$SIGMA
1 FIXED
Leonid
--
Leonid Gibiansky, Ph.D.
President
(ETA2)]
(0,0.316) ; 7 [THETA7, IIV ON KA, SD(ETA3)]
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 6/22/2012 12:36 PM, Yaming Hang wrote:
Dear NONMEM
Toufigh
It would help to see the plot. One possibility is that the plot is in
the log scale, and you have additive error component that plays larger
role at low concentrations.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
not be discussed in general,
it is specific to each problem.
Good example is monoclonal antibodies where you have total antibody
concentration measured while the blood contains free antibody + antibody
bound to the target.
Leonid
--
Leonid Gibiansky, Ph.D
should post messages from the address registered in the
list. If you changed the address, it needs to be reflected on the
server. I copied the nmusers, this reply will appear on the list.
Regards,
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 3/15/2012 6:47 PM, Adams, Jeb wrote:
My concerns with the Polyhedron website’s numbers are the use of gfortran 4.1.2
which was published in February of 2007
possible explanation is ALAG1 use: if the first observation is before
ALAG1 time, you will get zero prediction (and this error)
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel
The only way that I know is to use
SD=SQRT(IPRED**2*THETA(10)**2+THETA(11)**2)
Y=IPRED+SD*EPS(1)
RES=DV-IPRED
IWRES = RES/SD ; same as EPS(1)
$SIGMA
1 FIX
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 1/13/2012 1:43 PM, Paul Hutson wrote:
Thank you, Sebastien.
Moving A2 and A3 to the $ERROR block still gives me
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 1/13/2012 10:53 AM, Toufigh Gordi wrote:
Hi Justin (and others),
My computer has 3GB, running Windows 7 on a 32 bit machine
.
Regards,
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 12/22/2011 7:58 AM, Brogren Jacob wrote:
Dear nmusers,
Merry Holiday! (you may change
was defined as
100%*(single CPU run time)/(multiple CPU run time)/(number of processors)
Roughly, the model run on 11 processors was 10 times faster than the
single-processor run of the same model
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 10/25/2011 11:09 AM, fabr...@arlenda.com wrote:
Dear NMUsers,
Some pharmacokinetic data of a monoclonal antibody (IGG1 like
.
Still, each particular case should be approached individually, I would
not rule out any of the approaches (priors vs combining the data)
without knowing details of the specific case.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
non-zero IPREDi.
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 9/22/2011 9:26 AM, Rik Schoemaker wrote:
Dear all,
Can someone enlighten me on a NONMEM
Hi Andy,
Could you, please, provide an example of the model where Nonmem
computations are wrong? In my limited experience of comparison, they
always agree or very close to what I compute via IWRES.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President
the model that produces only the positive
productions. In this case, negative values will be treated as a random
noise (you need to have additive error component in this case), e.g.,:
Y=EFF+EPS(1)
or
Y=EFF*(1+EPS(1))+EPS(2)
Thanks
Leonid
--
Leonid Gibiansky
.
Regards,
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 7/11/2011 1:37 AM, Nick Holford wrote:
Leonid,
With regard to discarding runs at the boundary
to push to the parameter estimates that we
can accept, or change the bootstrap procedure (add stratification by
covariates, by dose level, by route of administration, etc.) so that all
data sets behave similarly.
Leonid
--
Leonid Gibiansky, Ph.D.
President
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 6/2/2011 11:44 AM, mdkz...@aol.com wrote:
All:
I have a data set following a constant rate 1-hour infusion where the
time of 1-hour sample
WITH OTHER INFORMATION
IN THE CONTROL STREAM AND INPUT MSF
The original problem ended with the rounding error 134; it looks like
the simulation step does not like it. Is this the indended behaviour?
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
Matt,
I was able to specify parameters explicitly and run simulations. So my
immediate problem is solved. I am still unsure what is the problem with
the MSF run.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
step (with UNCONDITIONAL option)
Any ideas of what is the problem?
Thanks!
Leonid
--
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
on the last row for each
individual in mytab
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 4/6/2011 11:00 AM, Martin Bergstrand wrote:
Dear Friederike,
Below
rather than curves in these plots
this is an indication of the time delay that need to be accounted for
either by effect compartment model or indirect response model.
Hope this helps
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
.
Regards
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 2/11/2011 10:35 AM, xin yi wrote:
Hi all,
I'm new to nonmem and would be grateful for some pointers
/3/2011 12:39 PM, Leonid Gibiansky wrote:
you can use ADNVAN9 $AES (see manual) although it is much better
(quicker and more stable) to solve them (if possible) analytically.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web: www.quantpharm.com
e
Ann,
RAM could be a problem if you like to run 16 jobs at once. If so, you
may need a 64-bit machine to support more than 4 Gb of RAM.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
I am sure, ours is the best one around :)
www.quantpharm.com
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 1/6/2011 10:59 AM, non...@optonline.net wrote
of the inter-occasion variability ETAs: if the
model is correct, they should be centered (for each occasion).
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
need to add dose, and this dose should be additional (regular, not
steady-state) dose, same as SS dose.
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 11
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:(301) 767 5566
On 11/1/2010 11:42 AM, Ann Rigby-Jones wrote:
Dear Matt All
I’m still battling I’m afraid…
Can’t seem to get past
Just out of curiosity, what type of problem will require 100K subjects?
If this is parametric, 15K should be sufficient to describe any number
of normal-type distributions. Is this a non-parametric model to catch a
very rare events?
Thanks
Leonid
--
Leonid
steps from the previously estimated model), but I cannot
find what was the problem and whether it was fixed.
Please, confirm
Thanks
Leonid
--
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
to describe the entire range of
available data, one can use this model until some experimental results
provide the data (and the need) to free and estimate those fixed parameters.
Thanks
Leonid
--
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web
101 - 200 of 295 matches
Mail list logo